Clinical Questions

• Should all patients with hepatitis C and elevated LFTs be referred for treatment with interferon?

• If not, who should be offered treatment and what factors determine this?

• What benefits are expected with treatment?

Previous slide

Next slide

Back to first slide

View graphic version